TriSalus Life Sciences, Inc.
TLSI
$5.73
$0.081.42%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 71.64% | -61.00% | 69.00% | -59.88% | -58.10% |
| Total Depreciation and Amortization | -0.52% | 8.33% | 29.33% | 2.17% | 459.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -84.07% | 64.05% | -220.30% | 252.48% | 105.26% |
| Change in Net Operating Assets | -88.03% | 31.97% | -426.84% | 29.28% | 15.13% |
| Cash from Operations | 37.81% | 49.93% | -45.32% | -3.47% | -10.43% |
| Capital Expenditure | 86.56% | 5.06% | -93.55% | -842.86% | -82.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 7.30% |
| Cash from Investing | 86.56% | 84.80% | -100.00% | 10.81% | -36.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 13.64% | 0.00% | 0.00% | 0.00% | 82.68% |
| Issuance of Common Stock | 3,444.71% | 20,775.00% | 22,443.75% | 6,196.00% | 304.76% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -100.00% | -- | -- | -- |
| Cash from Financing | 6,862.79% | -85.53% | 305.95% | -60.58% | -99.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 70.93% | -129.71% | 536.99% | -194.94% | -255.50% |